Trial Profile
Assessment of COPD Therapy From the Physicians Perspective Using Tiotropium as an Example.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 15 Sep 2010 Actual end date added to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 15 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.